Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31
- 30 October 2003
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 18 (1) , 113-119
- https://doi.org/10.1038/sj.leu.2403189
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q− syndrome from refractory anemia in primary myelodysplastic syndromeLeukemia Research, 2003
- Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patientsLeukemia Research, 2000
- Transcription Mapping of the 5q− Syndrome Critical Region: Cloning of Two Novel Genes and Sequencing, Expression, and Mapping of a Further Six Novel cDNAsGenomics, 2000
- The 5q-syndromeBlood, 1994
- Low‐dose ARA‐C consistently induces hematologic responses in the clinical 5q–syndromeAmerican Journal of Hematology, 1994
- All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot studyBlood, 1993
- The 5q- syndrome: a single-institution study of 43 consecutive patientsBlood, 1993
- Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5Blood, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Distinct haematological disorder with deletion of long arm of No. 5 chromosomeNature, 1974